Analyst Ratings for Bristol-Myers Squibb Co. (BMY) [Neutrals]
BMY Rating Summary
BMY Price Target Summary
- Highest: $92.00 (BMO Capital)
- Lowest: $63.00 (Morgan Stanley)
- Average: $77.86
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$77.86 (+3%)
* Over Last 12-Mos
Rating Score: 4.2 / 10
Percentile Rank: 39%

Rating Score: 4.2 / 10

Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
6/3/2022 | Raymond James | Dane Leone | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
75.07 (75.57) |
0.67% | Details |
12/9/2021 | Wells Fargo » Updated 5/17/2022 |
Mohit Bansal | New Coverage | Equal Weight (N/A) |
70.00 (65.00) |
57.13 (75.57) |
32.28% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |